| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -3,809,636 | -2,343,379 |
| Sale of short-term investments | 31,247,000 | 17,701,000 |
| Purchase of short-term investments | 32,004,951 | 20,103,127 |
| Purchase of patents | 46,333 | 35,215 |
| Purchase of trademarks | 16,887 | 8,841 |
| Net cash used in investing activities | -821,171 | -2,446,183 |
| Sale of common stock for cash, net of financing fees | 4,646,397 | 4,646,397 |
| Net cash provided by financing activities | 4,646,397 | 4,646,397 |
| Net increase (decrease) in cash and cash equivalents | 15,590 | -143,165 |
| Cash and cash equivalents at beginning of period | 574,485 | - |
| Cash and cash equivalents at end of period | 590,075 | - |
Nexalin Technology, Inc. (NXL)
Nexalin Technology, Inc. (NXL)